GenomeNext is a genomic informatics company dedicated to accelerating the promise and capability of predictive medicine and scientific discovery. The company commercializes genomic analysis tools and integrated systems for the evaluation of genetic variation and function. GenomeNext's advanced informatics and data management solutions are designed to simplify, expedite and enhance genetic analysis workflows. The company's customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agrigenomics, and consumer genomics companies.
Missing: GenomeNext's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: GenomeNext's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing GenomeNext
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
GenomeNext is included in 2 Expert Collections, including Omics.
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest GenomeNext News
Feb 20, 2018
To read the full story.... Mar Agilent This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.
GenomeNext Frequently Asked Questions (FAQ)
Where is GenomeNext's headquarters?
GenomeNext's headquarters is located at 175 South 3rd Street, Columbus.
What is GenomeNext's latest funding round?
GenomeNext's latest funding round is Debt.
How much did GenomeNext raise?
GenomeNext raised a total of $1.7M.
Who are the investors of GenomeNext?
Investors of GenomeNext include Hydra Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.